- The Federal Trade Commission's (FTC) investigation concerns potential collusion among baby-formula manufacturers as it examines whether companies like Abbott Laboratories (NYSE:ABT) and other formula manufacturers have engaged in collusion or coordination while bidding for state contracts.
- Furthermore, the agency is also exploring whether the coordination among these companies has had a broader impact on sales outside of the Women, Infants, and Children (WIC) formula-supply program, as stated by FTC Commissioner Alvaro Bedoya.
- Related: Abbott's Baby Formula Brouhaha: Judge Says No Harm, No Foul in Contamination Controversy.
- Abbott Laboratories has stated its cooperation with the FTC's investigation, Wall Street Journal reported.
- In previous correspondence, Abbott's lawyers denied any knowledge of collusion or coordination and expressed confusion regarding the factual basis of the agency's investigation.
- In January, the FTC had initially requested information from Abbott as a part of its investigation into companies bidding for state infant-formula supply contracts.
- Nestlé SA (OTC:NSRGF) (OTC:NSRGY) also received a request for information from the FTC and has responded accordingly.
- Reckitt Benckiser Group Plc (OTC:RBGLY) (OTC:RBGPF), another company frequently awarded WIC contracts, has not commented on the specific government investigations but stated its commitment to complying with regulatory and enforcement agencies' requests.
- While the FTC declined to provide further details, labeling them as nonpublic, the investigation is one among several initiated by federal agencies against Abbott, including a criminal investigation by the Justice Department prompted by the closure of one of Abbott's manufacturing plants last year, which contributed to a nationwide formula shortage.
- The recently revealed FTC documents shed light on Abbott's attempts to limit the information request and the FTC's rejection of their request.
- Price Action: ABT shares closed at $105.74 on Tuesday.
Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more